Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Bone Marrow Transplantation
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
April (1) 2001, Volume 27, Number 7, Pages 747-751
Table of contents    Previous  Abstract  Next   Full text  PDF
Case Report
Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation
M Miano1, E Lanino1, R Gatti2, G Morreale1, P Fondelli3, M E Celle4, M Stroppiano2, F Crescenzi1 and G Dini1

1BMT Unit, 'G Gaslini' Children's Hospital, Genova, Italy

2Department of Pediatrics, 'G Gaslini' Children's Hospital, Genova, Italy

3Department of Neuroradiology, 'G Gaslini' Children's Hospital, Genova, Italy

4Department of Neuropsychiatry, 'G Gaslini' Children's Hospital, Genova, Italy

Correspondence to: Dr G Dini, Dept of Hematology/Oncology, BMT Unit, 'G Gaslini' Children's Hospital, 16148 Genova Quarto, Italy

Abstract

Fucosidosis is a rare autosomal recessive lysosomal disorder caused by alpha-fucosidase deficiency. We report a child with fucosidosis, second daughter of non-consanguineous parents, for whom biochemical diagnosis followed clinical evidence of the disease in her older sister. Based on previous experiences, the indication to transplant was considered. Since she lacked a matched sibling, an unrelated marrow donor was found. At pre-hematopoietic stem cell transplantation evaluation, first signs of neurological involvement were clinically detectable. MRI showed diffuse hypomyelination and auditory brainstem responses and somatic-sensorial evoked potentials were altered. Visual evoked potentials were normal, tortuosity in the retinal veins and peripapillary hemorrhages were detected. Bone marrow transplantation conditioning was with a regimen of busulphan, thiotepa and cyclophosphamide; in vivo Campath 1G, cyclosporin A and short course methotrexate were given to prevent graft-versus-host disease. The patient engrafted rapidly and her post-transplant course was complicated by moderate graft-versus-host disease, transient episodes of idiopathic thrombocytopenic purpura, repeated septic complications and recurrent episodes of Sweet's syndrome. Sequential short tandem repeat polymorphisms on peripheral blood and bone marrow cells documented the persistence of donor engraftment. Follow-up showed a progressive rise of enzymatic levels. Psychomotor development improved, as confirmed by evaluation of evoked potentials and by MRI scanning. Bone Marrow Transplantation (2001) 27, 747-751.

Keywords

fucosidosis; hematopoietic stem cell transplantation; inborn errors

Received 21 June 2000; accepted 4 October 2000
April (1) 2001, Volume 27, Number 7, Pages 747-751
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2001 Nature Publishing Group